HSV-1's contribution as a vector for gene therapy

Nat Biotechnol. 2022 Sep;40(9):1316. doi: 10.1038/s41587-022-01449-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Genetic Therapy
  • Herpesvirus 1, Human* / genetics